- Nationwide Children’s Hospital and Ohio State University, both based in Columbus, joined a new $1 billion innovation district in Columbus focused on virus, pathogens, stem cell therapies and cancer research. Ohio State will invest $650 million, Nationwide Children’s Hospital will invest $350 million and JobsOhio will invest $100 million in the project.
- Cleveland Clinic is launching a new infectious disease research center through a $500 million innovation collaboration with the city of Cleveland and JobsOhio. Cleveland Clinic will put up $300 million in funds while JobsOhio will invest $200 million.
- Ascension Ventures, the healthcare venture arm of St. Louis-based Ascension, closed a $285 million strategic venture capital fund, bringing the firm’s total assets to more than $1 billion. The new fund is backed by 13 health system partners and is Ascension Ventures’ fifth venture capital fund.
- Providence’s digital health spinout DexCare closed a $20 million investment round backed by the Renton, Wash.-based health system’s innovation arm and Kaiser Permanente Ventures.
- Rochester, Minn.-based Mayo Clinic led an $8.2 million funding round for TripleBlind, a digital privacy and data sharing platform.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
